NSE: ERIS - Eris Lifesciences Limited

Yield per half year: +9.22%
Dividend yield: +0.59%
Sector: Healthcare

Share chart Eris Lifesciences Limited

en.porti.ru1600.001600.001400.001400.001200.001200.001000.001000.00800.00800.00600.00600.00Dec '23Dec '2320242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25
Download SVG
Download PNG
Download CSV

About Eris Lifesciences Limited

Eris Lifesciences Limited производит, продает и распространяет фармацевтическую продукцию в Индии. Он предлагает различные фирменные препараты в различных терапевтических областях, таких как сердечно-сосудистые, противодиабетические, противоинфекционные, жаропонижающие, витамины/питательные вещества, гастроэнтерология, респираторная, гинекология, педиатрия, неврология, психиатрия, обезболивающие/анальгетики, а также медицинские препараты. искусственное оплодотворение, косметология и дерматология. Eris Lifesciences Limited была зарегистрирована в 2007 году и находится в Ахмадабаде, Индия.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN INE406M01024
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.5945
Дивиденд ао 7.35
Сайт https://www.eris.co.in
Цена ао 1314.65
Change price per day: +5.31% (1314.65)
Change price per week: +1.28% (1366.95)
Change price per month: +11.97% (1236.35)
Change price per 3 month: +2.31% (1353.1)
Change price per half year: +9.22% (1267.55)
Change price per year: +64.15% (843.35)
Change price per 3 year: +95.03% (709.85)
Change price per 5 year: +210.54% (445.8)
Change price per year to date: +0.7789% (1373.7)
All parameters

Underestimation

Title Value Grade
P/S 5.76 2
P/BV 3.56 5
P/E 29.28 6
EV/EBITDA 20.28 5
Total: 5.88

Efficiency

Title Value Grade
ROA, % 7.32 2
ROE, % 16.39 5
Total: 4.33

Dividends

Title Value Grade
Div yield, % 0.5945 1.48
DSI 0.9167 9.17
Total: 4.49

Debt

Title Value Grade
Debt/EBITDA 3.98 3
Total: 4.8

Growth impulse

Title Value Grade
Yield Revenue, % 88.18 9
Yield Ebitda, % 84.4 9
Yield EPS, % 33.58 5
Total: 7.6
More

ETFShare, %Profitability for 1 year, %Dividends, %
iShares MSCI India Small-Cap ETF 0.18786 0.4625 0.96163
iShares MSCI Emerging Markets Small-Cap ETF 0.06762 7.67 2.7853
SPDR S&P Emerging Markets Small Cap ETF 0.03749 5.46 3.03583
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01266 12.46 3.59676
Dimensional Emerging Markets Core Equity 2 ETF 0.00978 15.96 3.34087
Dimensional World ex U.S. Core Equity 2 ETF 0.00349 13.06 3.62488
Vanguard FTSE All-World ex-US Small-Cap ETF 0 9.39 3.09932
0.059.212.92



Head Job title Payment Year of birth
Mr. Amit Indubhushan Bakshi Chairman & MD 48.78M 1975 (50 years)
Mr. Vijay S. Joshi President Medical N/A 1953 (72 years)
Mr. Sachin Shah Chief Financial Officer N/A 1980 (45 years)
Mr. Krishnakumar Vaidyanathan Executive Director & COO 44.85M 1974 (51 year)
Mr. Inderjeet Singh Negi Executive Director 12.4M 1971 (54 years)
Mr. Kaushal Kamlesh Shah Whole Time Director 6.99M 1979 (46 years)
Mr. Deepak Kapoor Senior Vice President N/A 1964 (61 year)
Mr. Milind Talegaonkar Compliance Officer & Company Secretary N/A
Mr. Gagan Atreja President of Sales & Marketing N/A 1968 (57 years)
Mr. Manish Kapoor Vice President 1977 (48 years)

Address: India, Ahmedabad, Shivarth Ambit - open in Google maps, open in Yandex maps
Website: https://www.eris.co.in